- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Breast Cancer and Rehabilitation in South Africa
Total 3031 results
-
Genentech, Inc.Active, not recruitingBreast CancerUnited States, Spain, Korea, Republic of, Australia, United Kingdom
-
Mylan Inc.Mylan GmbHCompletedBreast CancerSlovakia, Brazil, Chile, Georgia, Hungary, India, Latvia, Peru, Romania, Russian Federation, Serbia, South Africa, Thailand, Turkey, Ukraine
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Invasive Lobular Breast Carcinoma | Invasive Ductal Breast CarcinomaUnited States, Puerto Rico
-
NSABP Foundation IncHoffmann-La Roche; Genentech, Inc.Active, not recruitingTriple Negative Breast CancerUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingInvasive Breast Carcinoma | Triple-Negative Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage 0 Breast Cancer AJCC v6 and v7United States, Canada, Puerto Rico
-
Duke UniversityNational Cancer Institute (NCI)CompletedDepression | Breast Cancer | Weight ChangesUnited States
-
Dana-Farber Cancer InstituteGateway for Cancer Research; Susan G. Komen Breast Cancer FoundationActive, not recruiting
-
InventisBio Co., LtdCompleted
-
Evangelismos HospitalCompletedRehabilitationGreece
-
European Organisation for Research and Treatment...CompletedLung CancerItaly, South Africa, United Kingdom, Netherlands, Poland
-
Bristol-Myers SquibbCompletedCancer | Breast CancerBelgium, United States, Spain, France, Germany, Australia, Canada, Puerto Rico
-
US Oncology ResearchBristol-Myers Squibb; PfizerActive, not recruiting
-
ETOP IBCSG Partners FoundationCompletedBreast Cancer | Fatigue | Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its TreatmentBelgium, Switzerland, United Kingdom, Australia, Italy, New Zealand
-
GlaxoSmithKlineUniversity of Cape Town; African Organization for Research and Training in...CompletedCervical Cancer | Infections, PapillomavirusGhana, Nigeria, South Africa
-
NSABP Foundation IncNational Cancer Institute (NCI); Southwest Oncology Group; North Central Cancer...Completed
-
NSABP Foundation IncPfizer; Genomic Health®, Inc.CompletedBreast CancerUnited States, Canada
-
Genentech, Inc.CompletedBreast CancerBelgium, Israel, United States, Spain, Denmark, Germany, Hong Kong, Russian Federation, Australia, New Zealand, Korea, Republic of, Malaysia, Singapore, Italy, Czech Republic, France, Peru, Canada, United Kingdom, Chile, Thailand, Argentin... and more
-
Hoffmann-La RocheCompletedTriple Negative Breast CancerUnited States, Korea, Republic of, Belgium, Canada, Germany, United Kingdom, Argentina, Australia, Brazil, Finland, France, Greece, Hungary, Poland, Slovenia, Spain, Taiwan, Turkey, Japan, Singapore, Colombia, Bosnia and Herzegovina, Guatema... and more
-
Celldex TherapeuticsCompletedMetastatic gpNMB Over-expressing Triple Negative Breast CancerUnited States, France, Spain, Italy, Canada, Germany, Australia, Belgium, United Kingdom
-
Veru Inc.TerminatedMetastatic Breast CancerUnited States, Spain, Poland, Ukraine
-
Genentech, Inc.Hoffmann-La RocheCompletedBreast CancerUnited States, Belgium, France, Germany, United Kingdom, Spain
-
NSABP Foundation IncGenentech, Inc.; International Drug Development InstituteCompleted
-
PfizerCompletedMetastatic Breast CancerKorea, Republic of, Serbia, Argentina, Brazil, Japan, Peru, Turkey, United States, Slovakia, Mexico, Philippines, Poland, Romania, Hungary, India, Portugal, South Africa, Latvia, Thailand, Russian Federation, Ukraine, Chile, Czechia, ...
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States, Spain, China, France, Australia, Georgia, Poland, Bulgaria, Moldova, Republic of, Russian Federation, Ukraine
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Early Stage Triple-Negative Breast CarcinomaUnited States, Puerto Rico
-
AmgenActavis Inc.CompletedBreast CancerItaly, Hungary, Russian Federation, South Africa, Spain, Serbia, Belarus, Ukraine, Chile, Germany, Bulgaria, Greece, Poland, Canada, Brazil, Mexico, Romania, United Kingdom
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedBreast Cancer | FatigueUnited States
-
Pierre Fabre MedicamentCompletedBreast Cancer | MetastasesFrance, Ukraine, United Kingdom, Germany, Taiwan, Spain, Belarus, Belgium, Portugal, South Africa, Russian Federation, Austria, Italy, Argentina
-
GlaxoSmithKlineTerminatedNeoplasmsUnited States, Korea, Republic of, Canada, Spain, Australia, United Kingdom, France
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER2/Neu Over-expressing Locally Advanced Breast CancerChina, United States, France, Hungary, Turkey, Japan, Germany, Singapore, Italy, Poland, Spain, United Kingdom, Thailand, Israel, Australia, Belgium, Greece, Argentina, Czech Republic, Mexico, Slovakia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic Stage II Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Hormone Receptor... and other conditionsUnited States
-
Gilead SciencesMerck Sharp & Dohme LLCRecruitingTriple Negative Breast Cancer | PD-L1 PositiveUnited States, Taiwan, Belgium, Australia, Austria, Israel, Spain, Italy, Korea, Republic of, Japan, France, Netherlands, Canada, Turkey, Germany, Malaysia, Singapore, United Kingdom, Hong Kong, Hungary, Mexico, Switzerland, Puerto... and more
-
National Cancer Institute (NCI)Active, not recruitingMale Breast Carcinoma | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Puerto Rico
-
PfizerCompletedAdvanced Breast Cancer | Metastatic Breast CancerUnited States, Canada
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast CarcinomaUnited States, Peru
-
Heinrich-Heine University, DuesseldorfUnknown
-
Hoffmann-La RocheCompletedBreast CancerCanada, Germany, Korea, Republic of, Panama, Spain, Turkey, Brazil, Colombia, France, Hungary, Russian Federation, Taiwan, Thailand, Czechia, Italy, Estonia, Peru, South Africa, Sweden, Poland, Israel, Hong Kong, Mexico, Guatemala, Arge... and more
-
AbbVieCompletedMetastatic Breast CancerUnited States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Hungary, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, Norway, Po... and more
-
Hoffmann-La RocheCompletedEarly Breast CancerSpain, Korea, Republic of, Australia, Taiwan, Ukraine, Poland, Russian Federation, United States, Germany, Brazil, Hungary
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerRecurrent Breast Carcinoma | HER2/Neu Positive | Progesterone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Canada, Puerto Rico, Ireland
-
Accelerated Community Oncology Research NetworkAmgenCompletedBreast CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast Cancer | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompletedBreast CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Korea, Republic of, United Kingdom, Germany, Spain, Taiwan, Australia, Canada, Italy
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedBreast CancerFrance, Spain, Switzerland, Australia, Belgium, Austria, Peru, Germany, Italy, Japan, New Zealand, Sweden, Denmark, India, United States, Chile, Russian Federation, United Kingdom, Hungary, South Africa
-
National Cancer Institute (NCI)Southwest Oncology GroupCompletedRecurrent Breast Carcinoma | HER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States